Federal Register / Vol. 89, No. 240 / Friday, December 13, 2024 / Notices 101051 

hearing on October 3, 2024. All persons 

who requested the opportunity were 

permitted to participate. 

The Commission made these 

determinations pursuant to section 

751(c) of the Act (19 U.S.C. 1675(c)). It 

completed and filed its determinations 

in these reviews on December 10, 2024. 

The views of the Commission are 

contained in USITC Publication 5565 

(December 2024), entitled Steel 

Concrete Reinforcing Bar from Belarus, 

China, Indonesia, Latvia, Moldova, 

Poland, Ukraine: Investigation Nos. 

731–TA–873–875, 878–880, and 882 

(Fourth Review). 

By order of the Commission. 

Issued: December 10, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–29441 Filed 12–12–24; 8:45 am] 

BILLING CODE 7020–02–P 

JUDICIAL CONFERENCE OF THE 

UNITED STATES 

Committee on Rules of Practice and 

Procedure; Meeting of the Judicial 

Conference 

AGENCY: Judicial Conference of the 

United States. 

ACTION: Committee on Rules of Practice 

and Procedure; revised notice of open 

meeting. 

SUMMARY: The Committee on Rules of 

Practice and Procedure will hold a 

meeting in a hybrid format with remote 

attendance options on January 7, 2025 

in San Diego, CA as previously 

announced. The meeting is open to the 

public for observation but not 

participation. Please see the 

Supplementary Information section in 

this notice for instructions on observing 

the meeting. 

DATES: January 7, 2025 (meeting date) 

and December 31, 2024 (registration 

deadline for in person observation). 

ADDRESSES: An agenda and supporting 

materials will be posted at least 7 days 

in advance of the meeting at: https://

www.uscourts.gov/rules-policies/ 

records-and-archives-rules-committees/ 

agenda-books. 

FOR FURTHER INFORMATION CONTACT: H. 

Thomas Byron III, Esq., Chief Counsel, 

Rules Committee Staff, Administrative 

Office of the U.S. Courts, Thurgood 

Marshall Federal Judiciary Building, 

One Columbus Circle NE, Suite 7–300, 

Washington, DC 20544, Phone (202) 

502–1820, RulesCommittee_Secretary@

ao.uscourts.gov. 

SUPPLEMENTARY INFORMATION: To 

observe the meeting in person, 

individuals must contact the office 

listed above by 5 p.m. (eastern time) on 

December 31, 2024. After this deadline, 

only remote observation is permitted. 

Remote registration is available until the 

meeting date, provided it is completed 

before the projected end time. 

The announcement for this hearing 

was previously published in the Federal 

Register on October 28, 2024 at 89 FR 

85557. 

(Authority: 28 U.S.C. 2073.) 

Dated: December 9, 2024. 

Shelly L. Cox, 

Management Analyst, Rules Committee Staff. 

[FR Doc. 2024–29330 Filed 12–12–24; 8:45 am] 

BILLING CODE 2210–55–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1459] 

Bulk Manufacturer of Controlled 

Substances Application: National 

Center for Natural Products Research 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: National Center for Natural 

Products Research has applied to be 

registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to Supplementary 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before February 11, 2025. Such 

persons may also file a written request 

for a hearing on the application on or 

before February 11, 2025. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on September 5, 2024, 

National Center for Natural Products 

Research, Coy Waller Research Center, 

806 Hathorn Road, University, 

Mississippi 38677–1848 applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Marihuana Extract ......... 7350 I 

Marihuana ...................... 7360 I 

Tetrahydrocannabinols .. 7370 I 

The company plans to manufacture 

the listed controlled substances for 

product development and reference 

standards. In reference to drug codes 

7360 (Marihuana), and 7370 

(Tetrahydrocannabinols), the company 

plans to isolate these controlled 

substances from procured 7350 

(Marihuana Extract). In reference to 

drug code 7360, no cultivation activities 

are authorized for this registration. No 

other activities for these drug codes are 

authorized for this registration. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2024–29341 Filed 12–12–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1451] 

Importer of Controlled Substances 

Application: Groff NA Hemplex LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Groff NA Hemplex LLC has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplementary 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before January 13, 2025. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 13, 2025. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 


khammond on DSK9W7S144PROD with NOTICES